- Filed
- Jan 10, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Jan 6, 2025 | 53M sh |
| Shares Diluted restated | FY 2024 · Oct 31, 2023 | 54.17M sh |
| Stock Repurchased | FY 2024 · Oct 31, 2023 | $10.51M |
| Capex | FY 2024 · Oct 31, 2023 | $54.51M |
| Operating Cash Flow | FY 2024 · Oct 31, 2023 | $96.88M |
| Long Term Debt | FY 2024 · Oct 31, 2023 | $371.87M |
| Cash And Equivalents | FY 2024 · Oct 31, 2023 | $15.86M |
| Current Liabilities | FY 2024 · Oct 31, 2023 | $83.98M |
| Total Liabilities | FY 2024 · Oct 31, 2023 | $571.29M |
| Current Assets | FY 2024 · Oct 31, 2023 | $94.27M |
| Total Assets | FY 2024 · Oct 31, 2023 | $904.53M |
| Eps Diluted | FY 2024 · Oct 31, 2023 | $0.54 |
| Eps Basic | FY 2024 · Oct 31, 2023 | $0.54 |
| Sga Expense | FY 2024 · Oct 31, 2023 | $116.85M |
| Net Income | FY 2024 · Oct 31, 2023 | $31.79M |
| Operating Income | FY 2024 · Oct 31, 2023 | $61.45M |
| Gross Profit | FY 2024 · Oct 31, 2023 | $178.3M |
| Cost Of Revenue | FY 2024 · Oct 31, 2023 | $263.94M |
| Revenue | FY 2024 · Oct 31, 2023 | $411.25M |
| Stockholders Equity | FY 2024 · Oct 31, 2022 | $279.33M |